S Rijal

Summary

Publications

  1. ncbi Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal
    Suman Rijal
    BP Koirala Institute of Health Sciences, Ghopa, Dharan, Nepal
    Trop Med Int Health 15:21-8. 2010
  2. ncbi Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal
    S Rijal
    Department of Internal Medicine, B P Koirala Institute of Health Sciences, Dharan 056700, Nepal
    Trans R Soc Trop Med Hyg 104:225-9. 2010
  3. ncbi Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trop Med Int Health 9:724-9. 2004
  4. ncbi The economic burden of visceral leishmaniasis for households in Nepal
    S Rijal
    Department of Medicine, B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 100:838-41. 2006
  5. ncbi Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
    S Rijal
    B. P. Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 97:350-4. 2003
  6. ncbi Comparative study of kala-azar vector control measures in eastern Nepal
    M L Das
    Department of Microbiology, B P Koirala Institute of Health Sciences, Dharan, Nepal
    Acta Trop 113:162-6. 2010
  7. ncbi Sodium stibogluconate cardiotoxicity and safety of generics
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 97:597-8. 2003
  8. ncbi Lymphatic leishmaniasis--first case report from Nepal
    S K Sharma
    BP Koirala Institute of Health Sciences, Dharan, Nepal
    Southeast Asian J Trop Med Public Health 32:749-50. 2001
  9. ncbi Visceral leishmaniasis on the Indian sub-continent: a multi-centre study of the costs of three interventions for the control of the sandfly vector, Phlebotomus argentipes
    M Das
    B P Koirala Institute of Health Sciences, Dharan 56701, Nepal
    Ann Trop Med Parasitol 102:729-41. 2008
  10. ncbi Adenosine deaminase activity in sera of patients with visceral leishmaniasis in Nepal
    N Baral
    Department of Biochemistry, BP Koirala Institute of Health Sciences, Ghopa, BPKIHS, Dharan, Nepal
    Trop Doct 35:86-8. 2005

Collaborators

Detail Information

Publications18

  1. ncbi Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal
    Suman Rijal
    BP Koirala Institute of Health Sciences, Ghopa, Dharan, Nepal
    Trop Med Int Health 15:21-8. 2010
    ..We report data on prevalence rates of Leishmania donovani infection in ten communities in East Nepal...
  2. ncbi Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal
    S Rijal
    Department of Internal Medicine, B P Koirala Institute of Health Sciences, Dharan 056700, Nepal
    Trans R Soc Trop Med Hyg 104:225-9. 2010
    ..1), interruption of treatment (OR=4.3) and ambulatory treatment (OR=10.2). Early diagnosis and supervised treatment is of paramount importance to prevent treatment failures within the control programme...
  3. ncbi Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trop Med Int Health 9:724-9. 2004
    ....
  4. ncbi The economic burden of visceral leishmaniasis for households in Nepal
    S Rijal
    Department of Medicine, B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 100:838-41. 2006
    ..Direct costs consisted of 53% of the total cost, with 75% of this cost incurred before the patients actually received any treatment for VL. This study demonstrates how VL can lead to catastrophic expenditure for affected households...
  5. ncbi Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
    S Rijal
    B. P. Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 97:350-4. 2003
    ..These findings indicate that the spread of resistance to antimonials is already taking place in Nepal and that a policy to control further spread should be urgently implemented...
  6. ncbi Comparative study of kala-azar vector control measures in eastern Nepal
    M L Das
    Department of Microbiology, B P Koirala Institute of Health Sciences, Dharan, Nepal
    Acta Trop 113:162-6. 2010
    ..Hence, IRS was found most effective control measure to decrease vector density. LLINs were also found effective and can be considered as a promising alternative vector control tool in VL elimination initiative...
  7. ncbi Sodium stibogluconate cardiotoxicity and safety of generics
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 97:597-8. 2003
    ..These data show that every batch of generic SSG should be subject to rigorous quality control prior to use...
  8. ncbi Lymphatic leishmaniasis--first case report from Nepal
    S K Sharma
    BP Koirala Institute of Health Sciences, Dharan, Nepal
    Southeast Asian J Trop Med Public Health 32:749-50. 2001
    ..The bone marrow aspiration was negative for Leishmania donovani body. This is the first case of lymphatic leishmaniasis reported from Nepal...
  9. ncbi Visceral leishmaniasis on the Indian sub-continent: a multi-centre study of the costs of three interventions for the control of the sandfly vector, Phlebotomus argentipes
    M Das
    B P Koirala Institute of Health Sciences, Dharan 56701, Nepal
    Ann Trop Med Parasitol 102:729-41. 2008
    ..Various combinations of these interventions (based on country-specific social and economic factors) may, however, be the best and most cost-effective choice...
  10. ncbi Adenosine deaminase activity in sera of patients with visceral leishmaniasis in Nepal
    N Baral
    Department of Biochemistry, BP Koirala Institute of Health Sciences, Ghopa, BPKIHS, Dharan, Nepal
    Trop Doct 35:86-8. 2005
    ....
  11. ncbi Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine
    H Sangraula
    Department of Pharmacology, BP Koirala Institute of Health Sciences, Dharan, Nepal
    J Assoc Physicians India 51:686-90. 2003
    ..It is expected that in future we would have effective ways to prevent and treat all forms of leishmaniasis without discomforting the patient...
  12. ncbi Erythrocyte glutathione status in human visceral leishmaniasis
    D P Neupane
    Department of Biochemistry, B P Koirala Institute of Health Sciences, Dharan, Nepal
    Indian J Clin Biochem 23:95-7. 2008
    ..We concluded that visceral leishmaniasis patients are in oxidative stress which most likely induces the endogenous antioxidant such as GSH or its poor utilization by cells...
  13. ncbi Neurocycticercosis--a review
    J A Ansari
    BP Koirala Institute of Health Sciences, Dharan, Nepal
    Kathmandu Univ Med J (KUMJ) 1:48-55. 2003
  14. ncbi Chronic cough in thymoma
    K K Agrawaal
    Department of Internal Medicine, BPKIHS, Dharan, Nepal
    JNMA J Nepal Med Assoc 49:164-6. 2010
    ..After all the common causes for chronic cough have been ruled out, unusual causes should also be considered in the differential diagnosis...
  15. ncbi Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent
    M Boelaert
    Epidemiology and Disease Control Unit, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium
    Trans R Soc Trop Med Hyg 102:32-40. 2008
    ..FD-DAT and rK39 can be recommended for clinical practice on the Indian subcontinent. In East Africa, their clinical use should be carefully monitored. More work is needed to improve existing formats, and to develop better VL diagnostics...
  16. ncbi Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation
    S Decuypere
    Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, G12 8QQ, UK
    Parasitology 135:183-94. 2008
    ....
  17. ncbi Prospective evaluation and comparison of the direct agglutination test and an rK39-antigen-based dipstick test for the diagnosis of suspected kala-azar in Nepal
    F Chappuis
    Department of Community Medicine, Geneva University Hospital, Geneva, Switzerland
    Trop Med Int Health 8:277-85. 2003
    ..The rK39 dipstick is cheaper and easier to use than the DAT and could be used widely provided that both its performance and production remain stable...
  18. ncbi Pott's spine and paraplegia
    M P Gautam
    Bir Hospital, NAMS, Kathmandu, Nepal
    JNMA J Nepal Med Assoc 44:106-15. 2005
    ....